Literature DB >> 12646228

Serotype and VP1 gene sequence of a foot-and-mouth disease virus from Hong Kong (2002).

Qian Feng1, Xi Chen, Ou Ma, Yingying Liu, Mingxiao Ding, Richard A Collins, Lung-Sang Ko, Jun Xing, Lok-Ting Lau, Albert Cheung-Hoi Yu, Jianguo Chen.   

Abstract

The nucleotide sequence of the VP1 coding region of foot-and-mouth disease virus (FMDV) strain HKN/2002, isolated from a disease outbreak occurring in Hong Kong in February 2002, was determined and compared with the sequences of other FMDVs. The VP1 coding region was 639 nucleotides in length and encoded a protein of 213 amino acid residues. Comparison of the VP1 nucleotide sequence with those of other isolates indicated that HKN/2002 belonged to serotype O. A VP1-based sequence similarity tree of several South-east Asian FMDV-O isolates showed that HKN/2002 was most closely related to FMDV isolates found in Hong Kong from 1991 to 1999 and Taiwan in 1997. Comparison of the amino acid sequence of the major immunogenic region of HKN/2002 with that of the serotype O vaccine strain, O1/Manisa/Turkey/69, reveals significant similarity, indicating that current serotype O vaccines may offer some degree of protection against HKN/2002.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646228     DOI: 10.1016/s0006-291x(03)00250-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Alternative way to test the efficacy of swine FMD vaccines: measurement of pigs median infected dose (PID50) and regulation of live virus challenge dose.

Authors:  Dong Li; Zeng-Jun Lu; Bao-Xia Xie; Pu Sun; Ying-Li Chen; Yuan-Fang Fu; Zai-Xin Liu
Journal:  Virol J       Date:  2010-09-08       Impact factor: 4.099

2.  Evaluation of infectivity and transmission of different Asian foot-and-mouth disease viruses in swine.

Authors:  Juan M Pacheco; P W Mason
Journal:  J Vet Sci       Date:  2010-06       Impact factor: 1.672

3.  Comparison of immune responses against FMD by a DNA vaccine encoding the FMDV/O/IRN/2007 VP1 gene and the conventional inactivated vaccine in an animal model.

Authors:  Farahnaz Motamedi Sedeh; Hoorieh Soleimanjahi; AmirReza Jalilian; Homayoon Mahravani
Journal:  Virol Sin       Date:  2012-09-21       Impact factor: 4.327

4.  Complete nucleotide sequence of a Chinese serotype Asia1 vaccine strain of foot-and-mouth disease virus.

Authors:  Junzheng Du; Huiyun Chang; Guozheng Cong; Junjun Shao; Tong Lin; Youjun Shang; Zaixin Liu; Xiangtao Liu; Xuepeng Cai; Qingge Xie
Journal:  Virus Genes       Date:  2007-07-06       Impact factor: 2.332

5.  Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.

Authors:  Pinghua Li; Xingwen Bai; Pu Sun; Dong Li; Zengjun Lu; Yimei Cao; Yuanfang Fu; Huifang Bao; Yingli Chen; Baoxia Xie; Zaixin Liu
Journal:  BMC Vet Res       Date:  2012-05-16       Impact factor: 2.741

6.  Molecular characterization of amino acid deletion in VP1 (1D) protein and novel amino acid substitutions in 3D polymerase protein of foot and mouth disease virus subtype A/Iran87.

Authors:  Majid Esmaelizad; Saber Jelokhani-Niaraki; Khadije Hashemnejad; Morteza Kamalzadeh; Mohsen Lotfi
Journal:  J Vet Sci       Date:  2011-12       Impact factor: 1.672

7.  Early origin and global colonisation of foot-and-mouth disease virus.

Authors:  Pakorn Aiewsakun; Nakarin Pamornchainavakul; Chaidate Inchaisri
Journal:  Sci Rep       Date:  2020-09-17       Impact factor: 4.379

8.  Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.

Authors:  Thea Kristensen; Graham J Belsham
Journal:  PLoS Pathog       Date:  2019-01-18       Impact factor: 6.823

9.  Transboundary movements of foot-and-mouth disease from India to Sri Lanka: A common pattern is shared by serotypes O and C.

Authors:  L T Ranaweera; W W M U K Wijesundara; H S M Jayarathne; N J Knowles; J Wadsworth; A Gray; A M J B Adikari; C K Weebadde; S D S S Sooriyapathirana
Journal:  PLoS One       Date:  2019-12-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.